Literature DB >> 6743493

Enzyme induction by phenobarbitone and vitamin K1 disposition in man.

B K Park, A C Wilson, G Kaatz, E E Ohnhaus.   

Abstract

The plasma disposition of an intravenous pharmacological dose of vitamin K1 was determined in seven healthy volunteers before and after chronic administration of phenobarbitone (100 mg nocte). Phenobarbitone produced a significant increase in antipyrine clearance and 6 beta-hydroxycortisol excretion in all volunteers, indicating induction of hepatic microsomal mixed-function oxidase enzymes. However, phenobarbitone administration had no effect on the plasma disposition of vitamin K1. We conclude therefore, that vitamin K1 is not metabolized to any significant extent, by phenobarbitone-inducible mixed-function oxidase enzymes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743493      PMCID: PMC1463585          DOI: 10.1111/j.1365-2125.1984.tb05028.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Authors:  E E Ohnhaus; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

2.  Effect of warfarin on the metabolism of phylloquinone (vitamin K1):dose-response relationships in man.

Authors:  M J Shearer; A McBurney; A M Breckenridge; P Barkhan
Journal:  Clin Sci Mol Med       Date:  1977-06

3.  Effect of chronic anticonvulsant therapy on serum 25-hydroxycalciferol levels in adults.

Authors:  T J Hahn; B A Hendin; C R Scharp; J G Haddad
Journal:  N Engl J Med       Date:  1972-11-02       Impact factor: 91.245

4.  Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.

Authors:  K R Mountain; J Hirsh; A S Gallus
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

5.  Determination of 17-hydroxycorticosteroids with p-hydrazinobenzenesulfonic acid-phosphoric acid.

Authors:  A Sanghvi; L Taddeini; C Wight
Journal:  Anal Chem       Date:  1973-01       Impact factor: 6.986

6.  Clearance from plasma and excretion in urine, faeces and bile of an intravenous dose of tritiated vitamin K 1 in man.

Authors:  M J Shearer; C N Mallinson; G R Webster; P Barkhan
Journal:  Br J Haematol       Date:  1972-05       Impact factor: 6.998

7.  A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine.

Authors:  B K Park
Journal:  J Steroid Biochem       Date:  1978-10       Impact factor: 4.292

8.  Effects of clofibrate and warfarin alone and in combination on the disposition of vitamin K1.

Authors:  T D Bjornsson; P J Meffin; S E Swezey; T F Blaschke
Journal:  J Pharmacol Exp Ther       Date:  1979-09       Impact factor: 4.030

9.  Rifampicin and vitamin D metabolism.

Authors:  M J Brodie; A R Boobis; C T Dollery; C J Hillyard; D J Brown; I MacIntyre; B K Park
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

10.  Changes in phylloquinone epoxidase activity related to prothrombin synthesis and microsomal clotting activity in the rat.

Authors:  A K Willingham; J T Matschiner
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

View more
  4 in total

1.  Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy.

Authors:  P N Patsalos; J S Duncan; S D Shorvon
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

Review 2.  Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Authors:  M M Galteau; F Shamsa
Journal:  Eur J Clin Pharmacol       Date:  2003-11-06       Impact factor: 2.953

3.  Hepatic enzyme induction and vitamin K1 elimination in man.

Authors:  A K Scott; B P Haynes; K D Schinkel; E E Ohnhaus; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Should Cytochrome P450 Inducers be Used to Accelerate Clearance of Brodifacoum from Poisoned Patients?

Authors:  Israel Rubinstein; Richard van Breemen; Daniel G Nosal; Guy Weinberg; Ronald C Hershow; Douglas L Feinstein
Journal:  Drugs R D       Date:  2019-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.